CD34+ cell dose is an independent prognostic factor in patients with Hodgkin lymphoma and multiple myeloma who underwent autologous stem cell transplantation

Todorović-Balint, Milena R.; Jeličić, Jelena J.; Bila, Jelena S.; Vujić, Dragana S.; Balint, Bela J.; Kraguljac-Kurtović, Nada; Šefer, Dijana; Šerbić, Olivera; Lazić, Emilija; Antić, Darko A.; Anđelić, Boško M.; Smiljanić, Mihailo; Sretenović, Aleksandra M.; Mihaljević, Biljana S.

Results

eNauka > Results > CD34+ cell dose is an independent prognostic factor in patients with Hodgkin lymphoma and multiple myeloma who underwent autologous stem cell transplantation

Title:	CD34+ cell dose is an independent prognostic factor in patients with Hodgkin lymphoma and multiple myeloma who underwent autologous stem cell transplantation
Authors:	Todorović-Balint, Milena R. ; Jeličić, Jelena J. ; Bila, Jelena S. ; Vujić, Dragana S. ; Balint, Bela J. ; Kraguljac-Kurtović, Nada ; Šefer, Dijana ; Šerbić, Olivera ; Lazić, Emilija ; Antić, Darko A. ; Anđelić, Boško M.; Smiljanić, Mihailo; Sretenović, Aleksandra M.; Mihaljević, Biljana S. ;
Issue Date:	2017
Publication:	Bone marrow transplantation (43rd Annual meeting of the European Society for Blood and Marrow Transplantation, 26–29 March 2017, Marseille, France)
ISSN:	0268-3369 Bone Marrow Transplantation Search Idenfier
Publisher:	London : Nature Publishing Group
Type:	Conference Paper
Collation:	vol. 52 br. Suppl str. S463-S463
WoS-ID:	000424355301583
URI:	https://enauka.gov.rs/handle/123456789/817050
URL:	https://www.nature.com/articles/bmt2017134
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM